Thomas E. Witzig
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Metal complexes synthesis and properties
Papers in
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Alex A. Adjei (1 shared paper)Irene M. Ghobrial (1 shared paper)Thomas Matthew Habermann (2 shared papers)Joseph P. Colgan (1 shared paper)Luis F. Porrata (1 shared paper)G. S. Nowakowski (1 shared paper)Kay M. Ristow (1 shared paper)David James Inwards (1 shared paper)
- Journals
- Haematologica (1 paper)Leukemia (1 paper)CA A Cancer Journal for Clinicians (1 paper)Mayo Clinic Proceedings (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Thomas E. Witzig
8 papers receiving 1.6k citations
Thomas E. Witzig's Hit Papers
Peers
Comparison fields: 5 of 100
- Toxicology 73
- Oncology 396
- Molecular Biology 829
- Cancer Research 163
- Pathology and Forensic Medicine 189
Countries citing papers authored by Thomas E. Witzig
This map shows the geographic impact of Thomas E. Witzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Witzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Witzig more than expected).
Fields of papers citing papers by Thomas E. Witzig
This network shows the impact of papers produced by Thomas E. Witzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Witzig. The network helps show where Thomas E. Witzig may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Witzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Apoptosis Pathways in Cancer Therapy Hit paper breakdown → | 2005 | 1180 |
| 2 | 2011 | 176 | |
| 3 | 2009 | 100 | |
| 4 | Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents. | 2000 | 45 |
| 5 | 2016 | 41 | |
| 6 | 1991 | 27 | |
| 7 | 1996 | 14 | |
| 8 | 2003 | 13 | |
| 9 | 2006 | 1 |
About Thomas E. Witzig
Thomas E. Witzig is a scholar working on Hematology, Oncology, Cancer Research, Pathology and Forensic Medicine and Dermatology, having authored 9 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cell death mechanisms and regulation (2 papers), Cancer Genomics and Diagnostics (1 paper), Cancer and Skin Lesions (1 paper), NF-κB Signaling Pathways (1 paper), Estrogen and related hormone effects (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Toxicology (73 citations), Oncology (396 citations), Molecular Biology (829 citations), Cancer Research (163 citations) and Pathology and Forensic Medicine (189 citations). Thomas E. Witzig has collaborated with scholars based in United States and France. Frequent co-authors include Alex A. Adjei, Irene M. Ghobrial, Thomas Matthew Habermann, Joseph P. Colgan, Luis F. Porrata, G. S. Nowakowski, Kay M. Ristow, David James Inwards, S. N. Markovic and Ivana N. Micallef. Their work appears in journals such as Haematologica, Leukemia, CA A Cancer Journal for Clinicians, Mayo Clinic Proceedings and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.